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1. Introduction  
Congenital pseudarthrosis of the tibia (CPT) is one of the most challenging problems 
confronting pediatric orthopedic surgery. Fifty percent of cases are associated with 
neurofibromatosis, ten percent with fibrous dysplasia or Campanacci’s osteofibrous 
dysplasia and forty percent are idiopathic. CPT has a tendency to refracture until skeletal 
maturity. Fractures can even occur in adults. The refracture incidence is reversely 
proportional to age. Consequently success rate of treatment methods is also age dependent 
and directly proportional to age. This may be related to the activity of the pathologic tissue 
being greater at a younger age when growth rate and metabolism are at their greatest. It 
may also be a function of the diameter of the bone which is smaller at a younger age and 
therefore more prone to fracture.  
Various techniques for the management of CPT have been described. McFarland [32] 
described a bypass fibular graft, Boyd [3] and Boyd and Sage [4] described a double onlay 
graft taken from the opposite tibia combined with autologous iliac crest graft, Charnley [6] 
described intramedullary (IM) rods, and Sofield [41] added fragmentation and reversal of 
fragments. Campanacci and Zanoli [5] described a “fibula pro tibia” technique with fibular 
fixation to the pseudarthrosis site. Other methods include direct current or pulsed 
electromagnetic field, ipsilateral transfer of the fibula or contralateral free vascularized 
fibular transfer, circular external fixation, IM rodding, and combined external fixation and 
IM rodding. More recently, bone morphogenic protein (BMP) [28] and bisphosphonate 
therapy [20, 39] have been used. The results of all these methods have been variable. 
Refracture rates are high with all of these methods.  
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1.1 Pathology of CPT 
The pathology of CPT is still unknown. During the past 100 years, a number of theories have 
been suggested to explain the development of the disease. Today, interest concentrates 
mainly on the pathologic changes of the periosteum [19]. Codivilla [8] was the first to 
implicate the periosteum in the pathology of CPT. 
McElvenny [31] reported a markedly thickened, closely attached periosteum that caused 
constriction of the bone with subsequent atrophy and pseudarthrosis. The findings 
presented by McElvenny were echoed by Boyd [3] and Boyd and Sage [4], who suggested 
that CPT was caused by aggressive osteolytic fibromatosis and that those findings had been 
confirmed by specimens of amputated legs. Blauth et al. [1] reported the findings of a 
pathologic study of 10 patients with CPT and postulated that the thickened periosteum 
might be caused by myofibroblast overgrowth [21]. A more recent report [19] suggested that 
the thickened periosteum was caused by neural like cells that form a tight sheath around the 
small periosteal vessels causing narrowing or obliteration of vessels This results in 
disturbance of the blood circulation of the periosteum, which in turn results in impaired 
oxygen and nutrient supply of the subperiosteal bone with subsequent fracture and 
recalcitrant nonunion. 
Cho et al. [7] studied osteoclastic and osteoblastic activities of the periosteum of seven 
patients with CPT compared with those of two controls. They concluded that periosteal cells 
stay in undifferentiated form rather than growing into abnormal cells with variable 
responses to BMP-2. The osteoclastic activity of the periosteum was significantly higher than 
that of the control, and the authors postulated that not only pathogensis of CPT but also 
refracture after initial healing and resorption of bone grafting are related to osteoclastic 
activity of the periosteum. They concluded that while the fibrous hamartoma maintains 
some of the mesenchymal cell phenotypes they do not undergo differentiation in response 
to BMP. They also showed that these cells were also more osteoclastogenic than normal 
tibial periosteal cells.  
Schindeler et al, showed that NF1(+/-) mouse cells exhibited less osteogenic potential than 
NF1(+/+) cells (controls). In response to BMP the former revealed significantly less bone 
formation than the latter although BMP did stimulate bone formation in a heterotopic bone 
formation model. Co-treatment with zolidronic acid (ZA) lead to synergistic increase in 
bone formation in both groups. They concluded that biphosphonate-BMP combination 
therapy was superior to BMP therapy alone.  
1.2 Periosteal grafting  
Resection of hamartomatous fibrous tissue is part of many treatment protocols, but it does 
not ensure healing or prevent refracture. Codivilla recommended osteo-periosteal grafting 
more than 100 years ago [8]. Cambras (circa 1977, personal communication 1996) treated 
CPT with bone and periosteal grafting from the child’s mother, emphasizing the role of the 
periosteum to cure the disease. Paley [13] proposed periosteal grafting as a treatment option 
in 1995 based on observations he made during his first 8 years of treating this condition [37]. 
Paley’s periosteal grafting method was first published in a doctoral thesis by El Rossasy [14] 
in Egypt in 2001 and then in a book edited by Rozbruch in 2007 [13]. Paley’s periosteal 
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grafting method was used and reported on by Michael Weber [44] from Germany and Franz 
Grill from Austria [IPOS meeting 2006, Orlando, Florida]. A two center study combining the 
experience with periosteal grafting from Paley and Kocaoglu was published in 2008 by 
Thabet et al [42].  
The Paley method of periosteal grafting described by Thabet et al was the culmination of 
twenty years of experience in the treatment of CPT. Paley’s first report was in 1992. 
Followup of those and additional early Paley treated patients reported in El Rossasy’s 
doctorate thesis demonstrated a high refracture and retreatment rate. The initial treatment 
was using the Ilizarov method with bone grafting of the CPT site combined with hamartoma 
resection. The healing rate was nearly 100% but the refracture rate was over 50%. When an 
IM rod was added to the Ilizarov-bone grafting treatment the refracture rate drastically 
dropped. Clearly the Ilizarov fixation method was excellent at obtaining union but failed to 
maintain union. The IM rod was excellent at maintaining union and decreasing refracture. 
This was also the conclusion of the multicenter EPOS study by Grill et al [17]. The efficacy of 
the IM rod was also increased by rodding both bones in the leg rather than just one.  
Based both on the literature and on his own experience the other two factors that 
significantly helped decrease refracture were increasing the cross sectional area of union 
and eliminating angulation especially at the CPT site. Combining all of these principles 
Paley proposed the treatment method that was studied in the two center study reported in 
Thabet et al [42].  
2. Paley combined pharmacologic and surgical method of treatment of CPT 
Based on the new information from the recent patho-etiologic studies, Paley combined his 
periosteal grafting methodology [Thabet et al] with pharmacologic treatment using BMP 
and bisphosphonate infusion. This combination has reduced the refracture rate and 
accelerated the union rate as never previously observed or reported. While the union rate 
published in Thabet et al [42] was 100% there was a 40% refracture rate. All of these united 
when retreated with BMP and ZA infusion. Since the study in the 2008 publication Paley 
treated 15 additional cases of CPT. All united in 3-4 months and none have refractured with 
an average followup on average of 2 years (range 1-4 years). In addition to the previous 
method three changes were made to the original treatment methodology: 1) a cross union 
was created between the tibia and the fibula; 2) BMP was applied between the cancellous 
bone graft and the soft tissues as a surrounding layer including between the tibia and fibula; 
3) Zolidronic acid infusion was given with the index procedure and at the time of removal 
of the external fixation.  
2.1 Paley pharmacologic and surgical technique protocol (Fig 1) 
Pharmacologic: Biphosphonate Infusion: One week prior or one week after the surgery the 
patient is given a Zolidronic Acid infusion intravenously (0.2mg/kg) over 30 minutes. One 
hour later calcium gluconate 60 mg/kg is given intravenously over the course of one hour. 
The patient is given 2gm elemental calcium for 7 days and Vitamin D supplementation of 
400 IU for 14 days. Bone morphogenic protein which according to the FDA is considered an 
implant is nevertheless a protein and a growth factor. I therefore refer to its use herein as 
pharmacologic. Since it is applied in surgery it will be referred to there.  
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Surgery: The patient is placed supine, with a bump under the ipsilateral buttock, on a 
radiolucent table. The entire lower extremity and hemipelvis are prepped and draped free. 
The leg is exsanguinated and tourniquet applied. The pseudarthrosis site is approached 
through an anterior longitudinal incision. The thick periosteum is incised longitudinally. 
The periosteal incision ends at the point at which the periosteum thins to a normal 
thickness. Dissection between the periosteum and the surrounding soft tissues is carried out 
circumferentially around the tibia. Avoid injury to the anterior tibial artery laterally and the 
posterior tibial neurovascular bundle posterormedially. 
After the hamartomatous periosteum is excised circumferentially, the proximal segment of 
the tibia is split by using a fine saw (Fig. 1). The split is created in such a way that it does not 
fracture either arm of the split. The tibia resembles the old-fashioned one-piece wooden 
clothes pins. The fibular pseudarthrosis is approached by dissecting posterolateral to the 
tibia. The fibular periosteal hamartoma is also resected. 
 
Fig. 1a. Long AP radiograph of 16 month old girl with NF and CPT left tibia with a LLD. 
The distal tibial medullary canal is drilled open. The end of the distal tibia is inserted into 
the split of the proximal segment (occasionally when the CPT is in the mid-diaphysis 
instead of distal third the distal fragment is split the proximal is invanginated into the distal 
split). The proximal fibula is invaginated into a similar split of the distal fibula. The tibia and 
fibula are shortened by 1 to 2 cm. In a previously unoperated case, the only bone resection 
that is performed is the minimal required to open the medullary canal. In a previously 
operated case there may be dead bone present which should be resected. To determine what 
bone is alive vs dead, the tourniquet is released and all non bleeding bone is resected. A 
high speed burr is helpful in causing the bone to bleed while doing controlled debridement.  
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Fig. 1b. AP of the tibia before surgery. 
 
Fig. 1c.Lateral of the tibia before surgery. 
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Fig. 1d. AP of the tibia after surgery with telescopic IM rod in place and Ilizarov device in 
place. Note the walking extension on the external fixator that allows for equalization of the 
leg length and weightbearing during treatment.  
 
Fig. 1e. Lateral of the tibia after surgery. 
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Fig. 1f. Photograph of the child with the external fixator on. She had little pain and few pin 
site problems. 
An IM rod is inserted across the CPT site. The implant used depends on the age and 
diameter of the CPT bone. One can use a Kirschner wire or Steinmann pin in very-small-
diameter bone or a Rush rod or flexible titanium rod in larger diameter bones. The rod can 
be inserted from distal to proximal via the medial malleolus or from proximal to distal 
crossing the proximal physis. The distal to proximal technique is much more difficult 
because the medial malleolus is very medially located relative to the mid-diaphyseal line. 
There is a tendency to create a lateral translation deformity if the rod is not properly 
molded. Most recently, we have used the Paley-modified Fassier-Duval telescopic IM nail 
system (Pega Medical, Inc. Laval, Quebec, Canada) from proximal to distal. The Paley 
modification of this nail allows locking into the distal tibial epiphysis using a threaded 
1.6mm Kirschner wire. It is preferable to avoid rodding across the ankle joint to prevent 
stiffness of the ankle joint and permanent poor push-off strength [23]. The fibula should be 
rodded retrograde from the lateral malleolus using a wire of between 1-2mm in diameter. It 
is important to coordinate the rodding and shortening of the tibia and fibula so that one 
bone does not impede the shortening of the other bone.  
An incision is then made along the iliac crest. The apophysis is split and the medial 
periosteum with the iliacus muscle reflected medially off the ilium. The cancellous bone 
between the cortical tables of the ilium is harvested. In young children this will not yield 
enough bone. Therefore the tables can be split with a sharp osteotome towards the roof of 
the acetabulum. There is a large amount of cancellous bone located in the supra-acetabular 
region. This can be reached with a curette after splitting the tables using image intensifier 
guidance. Even in a one year old child there is ample cancellous bone to be found in the 
supra-acetabular region. The bone in the donor site reconstitutes after the harvest.  
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Fig. 1g. Long AP radiograph standing showing the remaining LLD that will be treated at a 
later date. The tibia and fibular are healed. 
 
Fig. 1h. AP radiograph of the tibia showing the Fassier-Duval with the distal Paley 
modificaiton (locking to the distal epiphysis with a threaded k-wire). The tibia and fibula 
show a cross union and both bones show are now solidly united.  
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The best place to procure periosteum is beneath the iliacus muscle. If more is needed then 
the periosteum beneath the gluteal muscles can also be harvested by reflecting the lateral 
half of the apophysis off of the lateral table of the ilium. A knife is used to incise the 
periosteum in as long and as wide a rectangular piece as possible. The periosteum is then 
separated from the overlying muscle. The periosteum immediately shrinks to a quarter its 
original size. To restore some of its size, it is placed through the skin graft mesher and 
expanded. The meshed periosteum is expanded and then wrapped around the invaginated 
bone ends of the pseudarthrosis site. It is important that the cambium layer face the bone. To 
apply the periosteum two sutures can be tied to two of the corners of the rectangular graft. 
The graft is then pulled around the posterior aspect of the bone and sutured to itself. The 
same is done to the fibular pseudarthrosis site. The cancellous bone graft is then placed 
circumferentially around the pseudarthrosis site and filled into the space between the two 
bones. Finally bone morphogenic protein (BMP-2; Infuse, Medtronics, Memphis, TN) is 
placed around the bone graft between the bone graft and the surrounding soft tissues. The 
bone grafting and BMP are especially located in the space between the tibia and fibula to 
create a cross union. The wound is then closed over a Hemovac drain. 
After closure, an Ilizarov all-wire frame is applied to the limb. This requires three wires in 
the proximal metaphysis (two counter opposed olive wires and one smooth wire), three 
distal wires, and foot fixation. The wires should not be in contact with the IM rod. A 
walking ring is applied postoperatively so that the patient does not have to bear weight on 
the foot. The main purpose of the fixator is to give rotatory control and stability to the 
pseudarthrosis site.  
3. Post-operative management 
The patient’s wound is checked two weeks after surgery. Radiographs are obtained at 6 and 
12 weeks after surgery. The bone is usually united by 12 weeks after surgery. The external 
fixator can be removed once radiographic union is confirmed and a long leg walking cast 
applied. After removal and after the swelling decreases the patient should be measured for a 
knee-ankle-foot orthotic with a free knee hinge and a solid ankle. As the patient grows the 
brace should be remade. Eventually (over age 6), an articulated ankle is added. As the 
patient gets older the length of the brace is reduced. Then the thigh cuff is removed and only 
a total contact articulated AFO or PTB brace used. When the patient is older (over age 10 a 
gator brace (no foot part with lateral and medial malleolar flanges) is used. Brace wear at all 
times including during sleep and swimming is used until skeletal maturity. The only time 
the brace is taken off is for bathing and for physical therapy. Sports and other activities are 
allowed while wearing the brace. Patients treated engaged in wrestling, surfing, skiing, 
cycling, etc.  
The IM rod should be changed as needed. If a telescopic rod is used it should be changed to 
a larger diameter rod as the patient grows. Since the length of the bone doubles from age 3 
in girls and 4 years old in boys till skeletal maturity, the telescopic rod has to be changed 
once before maturity and once before age 4. Zolidronic acid infusion should be given with 
each rodding surgery.  
Hemiepiphysiodesis is also performed if a valgus ankle or knee is present. The presence of 
the rod does not impede the use of a hemi-epiphysiodesis screw plate device.  
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4. Discussion 
The natural history of CPT is recalcitrant nonunion, atrophy of the bone and the leg, 
progressive LLD and deformity, and recurrent refracture even after union is acheived in 
surgery [3, 4, 22, 29, 33]. The primary objective of treatment for CPT is to obtain union. The 
secondary objective is to maintain union. In addition, many associated deformities of length 
and angulation should be addressed in the comprehensive management of CPT. Therefore, 
unless all patients have reached skeletal maturity, the refracture rate reported is always 
lower than actual [3, 4, 33].  
The main surgical options for treatment of CPT are vascularized fibular grafting, IM 
stabilization, external fixation with a circular frame, and amputation [9−11, 17, 18, 26, 30, 35]. 
Electric stimulation has also been studied [37, 38] 
Paley et al. [35] presented a report of 15 patients who had 16 tibiae with congenital 
pseudarthrosis. The mean patient age was 8 years, the rate of union was 94% in 15 patients 
with Ilizarov frames, refracture occurred in five tibiae (31%), and the mean followup 
duration was 4 years. 
Boero et al. [2] presented a report of 21 patients with neurofibromatosis treated with Ilizarov 
frames. The mean patient age was 8.8 years. The primary union rate was achieved in 17 of 21 
(81%) patients. Refracture occurred in four of the 17 patients (19%), and the minimum 
followup duration was 2 years. 
The European Paediatric Orthopaedic Society (EPOS) multicenter study [17] of 340 patients 
with CPT reported a 75% healing rate achieved with Ilizarov external fixation and 
recommended the use of prophylactic IM rodding to prevent refracture. 
In a series of 17 tibiae with CPT treated by Paley and Herzenberg, half of which were 
followed up to skeletal maturity, the mean patient age was 8 years, union was obtained in 
100% of the patients, and refracture occurred in 68% when the Ilizarov device without IM 
rodding was used [14]. When IM rodding was combined with external fixation, the 
refracture rate dropped to 29%. 
Ohnishi et al. [34] reported 73 cases that were treated with different treatment protocols: 26 
with Ilizarov fixation, 25 with vascularized fibular grafting, seven with the combination of 
the previous two techniques, six with IM rodding combined with free bone grafting, five 
with plating and grafting, and the remaining four with different treatment protocols. The 
average patient age was 5 years. Union was achieved in all patients treated with Ilizarov 
fixation (four experienced refracture), 22 of 25 (88%) patients treated with free vascularized 
fibular grafting (one experienced refracture), and all patients treated with both fibular 
grafting and Ilizarov fixation. 
IM rodding is an alternative treatment option to achieve and maintain union, although the 
reported results are variable. Joseph and Mathew [24] reported 14 skeletally immature 
patients treated with IM rodding and double onlay autogenous bone grafting from the 
opposite tibia. The mean patient age was 4.5 years, the union rate was 86%, the mean 
followup duration was 3 years, and the refracture rate was 21% (three of 14). 
Johnston [23] presented a report of 23 patients treated with different techniques of IM 
rodding and grafting. The mean patient age was 2 years 4 months, the mean followup 
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duration was 9 years, the primary union rate was 87%, and 13% had persistent nonunion 
and bad outcomes. The author noted that two important factors for the best outcome for 
patients with CPT were perfect limb alignment and the use of IM rods to achieve union, 
prevent refracture, and maintain alignment. 
Kim and Weinstein [27] presented a report of 11 patients with 12 tibiae with congenital 
pseudarthrosis treated with IM rodding and free bone grafting. The mean patient age at the 
time of the index operation was 2.5 years. Four of the 11 patients healed after the primary 
index operation. Two of the four experienced refracture; one healed with a long lower limb 
cast, and the other healed after the index operation was repeated. The other seven did not 
heal after the index operation. Four of them achieved healing after undergoing multiple 
surgical procedures (one required free vascularized fibular grafting, and three required 
repeated IM rodding and grafting; one of the three had nonunion, one needed Syme 
amputation, and one had a failed Sofield procedure). Healing could not be achieved in the 
other three patients (two underwent below-knee amputation, and one had persistent 
nonunion at the latest followup visit). Kim concluded that IM rodding provides more 
predictable results in cases of late-onset pseudarthrosis. 
Dobbs et al. [9, 10] reported the long-term followup (mean followup duration, 14.2 years) of 
21 patients with CPT (mean patient age, 5.1 years) treated with IM rodding and bone 
grafting. The primary union rate was 86% (18 patients), and three patients required 
additional bone grafting to achieve union. Twelve patients (57%) experienced refracture, 
and five (24%) required amputation. 
Free vascularized fibular grafting had been described by several authors as a good option 
for acheiving union in patients with CPT, although it is associated with many drawbacks, 
including nonunion, refracture, and recurrent nonunion at one site of the graft end [11, 16, 
25, 45]. Angular deformity of the affected tibia (valgus or anterior bowing) has been 
reported. The deformities usually are progressive and require further treatment [15, 25, 45]. 
Donor site morbidity, such as progressive ankle valgus with proximal migration of the distal 
fibula, is another problem associated with vascularized fibular grafting [15, 25, 45]. The 
tibiofibular synostosis can only delay but not prevent ankle valgus [15]. 
Weiland et al. [45] presented a report of 19 patients with a 95% union rate. Initial failure to 
achieve union occurred in 26% (five of 19 patients), and those patients required secondary 
procedures to achieve union (four healed and one underwent amputation). 
Gilbert [16] reported the long-term followup of 29 patients who had CPT treated with 
microvascular fibular grafting, all of whom had reached skeletal maturity. The union rate 
was 94% with a mean healing time of 6 months. The mean patient age at the time of the 
index operaion was 5.5 years, the refracture rate was 14%, and the reccurence rate was 7%. 
Donor site morbidity occurred in 24%, tibial deformity (valgus and anterior bowing ) 
occurred in 24%, progressive LLD occurred in 7%, and no ampuation was recorded. 
The EPOS study [26, 39] reported a healing rate of 61% (19 of 31 patients). Seven of the 19 
healed patients required additional procedures, such as grafting, plating, or IM rodding. 
The remaining 12 healed after the primary treatment and did not require additional surgery. 
Three patients (10%) required amputations, seven (23%) had not healed, and five (16%) 
experienced fracture of the transfered fibula. 
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Toh et al. [43] reported seven cases of CPT treated with vascularized fibular graft, with a 
mean followup duration of 12.1 years. Casting or monolateral external fixation was used in 
the first cases; an Ilizarov fixator was used as a postopertative immobilization tool in one 
case. The author concluded that the best outcome can be acheived with combined 
vascularized fibular grafting and Ilizarov external fixation as a method of postopertaive 
fixation. 
El-Gamal et al. [12] reported three cases of CPT treated with vascularized fibular grafting 
combined with Ilizarov fixation to distract the fibular graft to correct LLD with a single 
operation. They called it ‘telescoping vascularized fibular graft’. The mean patient age was 9 
years, and the mean followup duration was 2 years. Union was achieved in all cases. One 
patient experienced refracture, and another patient experienced ankle valgus of the affected 
site. 
Amputation is an option in cases of CPT [18, 30]. Its incidence varies from series to series. 
McCarthy [30] noted that foot condition, number of operations, and severity of LLD are the 
factors that determine the need for amputation. 
Pharmacologic therapuetic solutions for CPT recently have become available: BMP-2, BMP-7 
and bisphosphonate therapy (ZA) [20, 28, 40]. Lee et al. [28] reported five cases of CPT 
treated with BMP-7 combined with corticocancellous allograft and IM rodding combined 
with external fixation. The mean patient age was 6 years, and the mean followup duration 
was 14 months. The authors conluded that the use of recombinant human BMP-7 is not 
enough to overcome the poor healing environment associated with CPT. Little and 
colleagues [20, 40] used bisphosphonate (ZA) for patients with CPT to control the activity of 
osteoclasts to promote union and prevent the bone graft from resorption.  
Thabet, Paley, Kocoaglu et al [42] conducted a retrospective study of 20 patients with CPT 
who were treated with periosteal grafting and bone grafting combined with IM rodding of 
the tibia and fibula and circular external fixation by the senior authors between 1997 and 
2006 at two centers. The mean age at the index operation was 4.2 years (age range, 1−11.3 
years). Eleven patients (55%) had neurofibromatosis, in seven patients (35%) the condition 
was idiopathic, and two patients (10%) had osteofibrous dysplasia. Twelve patients (60%) 
had no previous surgery, and eight patients (40%) had undergone at least one unsuccessful 
operation (range, 0−14). All patients had established pseudarthrosis. Union was achieved in 
all patients (100%). The mean time spent in external fixation was 5.2 months (range, 3−12 
months). Limb lengthening was achieved in 12 patients. The mean lengthening amount was 
2.5 cm (range, 0−7 cm); epiphysiodesis of the opposite side was performed in one patient. 
Refracture occurred in eight patients: six experienced one refracture each, and two 
experienced two refractures each. Six of the eight patients with refracture had fibular 
pseudarthrosis. The mean time between the index operation and refracture was 2.3 years 
(range, 1−5.8 years), and the mean time between the index operation and second refracture 
was 4.7 years. The mean age at the index operation of patients who experienced refracture 
was 4 years (range, 1−7.3 years). The mean followup duration was 4.3 years (range, 2−10.7 
years). All of the refractures were treated and all healed with surgery.  
Most recently Paley studied 15 cases treated by the combined pharmacologic and surgical 
management method described above. The age range was from 1-10 years (mean 4 years). All 
patients united. There were no refractures. The average followup was 2 years (range 1-4).  
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Based on these results there is reason to believe that combining BMP and bisphosphonate 
treatment in clinical practice is a useful adjunct as was shown in the animal model [40]. In a 
review of CPT, Johnston and Birch [22] advocated using BMP as an adjuvant treatment in all 
primary and recalcitrant cases. Despite optimism with the use of BMP, one must also 
consider theoretical risk of tumorgenesis because BMP stimulates the RAS pathway, which 
is also a tumor pathway. Patients with CPT have a propensity for both benign and 
malignant tumors. Although there has never been a report of such a complication, it should 
be discussed with patients since rhBMP is not FDA-approved for children or for CPT. 
The Paley method of combined pharmacologic and surgical management is a shotgun 
approach to management of this potentially devastating problem. It optimizes the 
mechanical [33]and biologic environment for the CPT. It is impossible to identify which 
factor is more important for the healing of CPT since no control group or comparison study 
has been done. Since this is a rare disease and failure is devastating it is more important to 
have a successful method than to be certain which component of the treatment regimen is 
the most important to achieving successful union. As newer pharmacologic therapeutics and 
better understanding of the patho-etiology of this disease occur, the combined 
pharmacologic surgical technique will morph to include newer technologies and 
therapeutics. Meanwhile the combination treatment; hamartoma resection, periosteal 
grafting, bone grafting, internal rodding, external fixation, tibio-fibular cross union, BMP 
and bisphosphonate pharmacologic manipulation are the best current combination 
treatment for CPT.  
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